Table of Contents

2018-2023 Global Ketorolac Tromethamine Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Ketorolac Tromethamine Consumption 2013-2023
  • 2.1.2 Ketorolac Tromethamine Consumption CAGR by Region
• 2.2 Ketorolac Tromethamine Segment by Type
  • 2.2.1 Injection
  • 2.2.2 Ophthalmic
  • 2.2.3 Nasal
  • 2.2.4 Oral tablet
• 2.3 Ketorolac Tromethamine Consumption by Type
  • 2.3.1 Global Ketorolac Tromethamine Consumption Market Share by Type (2013-2018)
  • 2.3.2 Global Ketorolac Tromethamine Revenue and Market Share by Type (2013-2018)
  • 2.3.3 Global Ketorolac Tromethamine Sale Price by Type (2013-2018)
• 2.4 Ketorolac Tromethamine Segment by Application
  • 2.4.1 Short-term treatment of pain
  • 2.4.2 Ophthalmic Surgery
• 2.5 Ketorolac Tromethamine Consumption by Application
  • 2.5.1 Global Ketorolac Tromethamine Consumption Market Share by Application (2013-2018)
  • 2.5.2 Global Ketorolac Tromethamine Value and Market Share by Application (2013-2018)
  • 2.5.3 Global Ketorolac Tromethamine Sale Price by Application (2013-2018)

3 Global Ketorolac Tromethamine by Players

• 3.1 Global Ketorolac Tromethamine Sales Market Share by Players
  • 3.1.1 Global Ketorolac Tromethamine Sales by Players (2016-2018)
  • 3.1.2 Global Ketorolac Tromethamine Sales Market Share by Players (2016-2018)
• 3.2 Global Ketorolac Tromethamine Revenue Market Share by Players
  • 3.2.1 Global Ketorolac Tromethamine Revenue by Players (2016-2018)
  • 3.2.2 Global Ketorolac Tromethamine Revenue Market Share by Players (2016-2018)
• 3.3 Global Ketorolac Tromethamine Sale Price by Players
• 3.4 Global Ketorolac Tromethamine Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Ketorolac Tromethamine Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Ketorolac Tromethamine Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Ketorolac Tromethamine by Regions

• 4.1 Ketorolac Tromethamine by Regions
  • 4.1.1 Global Ketorolac Tromethamine Consumption by Regions
  • 4.1.2 Global Ketorolac Tromethamine Value by Regions
• 4.2 Americas Ketorolac Tromethamine Consumption Growth
• 4.3 APAC Ketorolac Tromethamine Consumption Growth
• 4.4 Europe Ketorolac Tromethamine Consumption Growth
• 4.5 Middle East & Africa Ketorolac Tromethamine Consumption Growth

5 Americas

• 5.1 Americas Ketorolac Tromethamine Consumption by Countries
  • 5.1.1 Americas Ketorolac Tromethamine Consumption by Countries (2013-2018)
  • 5.1.2 Americas Ketorolac Tromethamine Value by Countries (2013-2018)
• 5.2 Americas Ketorolac Tromethamine Consumption by Type
• 5.3 Americas Ketorolac Tromethamine Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Ketorolac Tromethamine Consumption by Countries
  • 6.1.1 APAC Ketorolac Tromethamine Consumption by Countries (2013-2018)
  • 6.1.2 APAC Ketorolac Tromethamine Value by Countries (2013-2018)
• 6.2 APAC Ketorolac Tromethamine Consumption by Type
• 6.3 APAC Ketorolac Tromethamine Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Ketorolac Tromethamine by Countries
  • 7.1.1 Europe Ketorolac Tromethamine Consumption by Countries (2013-2018)
  • 7.1.2 Europe Ketorolac Tromethamine Value by Countries (2013-2018)
• 7.2 Europe Ketorolac Tromethamine Consumption by Type
• 7.3 Europe Ketorolac Tromethamine Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Ketorolac Tromethamine by Countries
  • 8.1.1 Middle East & Africa Ketorolac Tromethamine Consumption by Countries (2013-2018)
  • 8.1.2 Middle East & Africa Ketorolac Tromethamine Value by Countries (2013-2018)
• 8.2 Middle East & Africa Ketorolac Tromethamine Consumption by Type
• 8.3 Middle East & Africa Ketorolac Tromethamine Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.2 Ketorolac Tromethamine Distributors
• 10.3 Ketorolac Tromethamine Customer

11 Global Ketorolac Tromethamine Market Forecast

• 11.1 Global Ketorolac Tromethamine Consumption Forecast (2018-2023)
• 11.2 Global Ketorolac Tromethamine Forecast by Regions
  • 11.2.1 Global Ketorolac Tromethamine Forecast by Regions (2018-2023)
  • 11.2.2 Global Ketorolac Tromethamine Value Forecast by Regions (2018-2023)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Ketorolac Tromethamine Forecast by Type
• 11.8 Global Ketorolac Tromethamine Forecast by Application

12 Key Players Analysis

• 12.1 Pfizer
  • 12.1.1 Company Details
  • 12.1.2 Ketorolac Tromethamine Product Offered
  • 12.1.3 Pfizer Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.1.4 Main Business Overview
  • 12.1.5 Pfizer News
• 12.2 Omeros Corporation
  • 12.2.1 Company Details
  • 12.2.2 Ketorolac Tromethamine Product Offered
  • 12.2.3 Omeros Corporation Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.2.4 Main Business Overview
  • 12.2.5 Omeros Corporation News
• 12.3 Egalet US Inc.
  • 12.3.1 Company Details
  • 12.3.2 Ketorolac Tromethamine Product Offered
  • 12.3.3 Egalet US Inc. Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.3.4 Main Business Overview
  • 12.3.5 Egalet US Inc. News
• 12.4 Allergan
  • 12.4.1 Company Details
  • 12.4.2 Ketorolac Tromethamine Product Offered
  • 12.4.3 Allergan Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.4.4 Main Business Overview
  • 12.4.5 Allergan News
• 12.5 Dr. Reddy’s Laboratories
  • 12.5.1 Company Details
  • 12.5.2 Ketorolac Tromethamine Product Offered
  • 12.5.3 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.5.4 Main Business Overview
  • 12.5.5 Dr. Reddy’s Laboratories News
• 12.6 Teva
  • 12.6.1 Company Details
  • 12.6.2 Ketorolac Tromethamine Product Offered
  • 12.6.3 Teva Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.6.4 Main Business Overview
  • 12.6.5 Teva News
• 12.7 Mylan
  • 12.7.1 Company Details
  • 12.7.2 Ketorolac Tromethamine Product Offered
  • 12.7.3 Mylan Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.7.4 Main Business Overview
  • 12.7.5 Mylan News
• 12.8 West Ward Pharmaceuticals
  • 12.8.1 Company Details
  • 12.8.2 Ketorolac Tromethamine Product Offered
  • 12.8.3 West Ward Pharmaceuticals Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.8.4 Main Business Overview
  • 12.8.5 West Ward Pharmaceuticals News
• 12.9 Fresenius Kabi
  • 12.9.1 Company Details
  • 12.9.2 Ketorolac Tromethamine Product Offered
  • 12.9.3 Fresenius Kabi Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.9.4 Main Business Overview
  • 12.9.5 Fresenius Kabi News
• 12.10 Apotex
  • 12.10.1 Company Details
  • 12.10.2 Ketorolac Tromethamine Product Offered
  • 12.10.3 Apotex Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.10.4 Main Business Overview
  • 12.10.5 Apotex News
• 12.11 Sandoz
• 12.12 Amphastar Pharmaceuticals
• 12.13 Gland Pharma Limited
• 12.14 Akorn
• 12.15 Sun Pharmaceutical
• 12.16 Sagent Pharmaceuticals
• 12.17 Aurobindo Pharma

13 Research Findings and Conclusion

Ketorolac tromethamine, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level.

According to this study, over the next five years the Ketorolac Tromethamine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Ketorolac Tromethamine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Ketorolac Tromethamine market by product type, application, key manufacturers and key regions and countries.

This study considers the Ketorolac Tromethamine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
Injection
Ophthalmic
Nasal
Oral tablet
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Short-term treatment of pain
Ophthalmic Surgery

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Omeros Corporation
Egalet US Inc.
Allergan
Dr. Reddy’s Laboratories
Teva
Mylan
West Ward Pharmaceuticals
Fresenius Kabi
Apotex
Sandoz
Amphastar Pharmaceuticals
Gland Pharma Limited
Akorn
Sun Pharmaceutical
Sagent Pharmaceuticals
Aurobindo Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Ketorolac Tromethamine consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Ketorolac Tromethamine market by identifying its various subsegments.
Focuses on the key global Ketorolac Tromethamine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Ketorolac Tromethamine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Ketorolac Tromethamine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.